Corticosteroids in the Management of Severe Coccidioidomycosis.

Abstract

BACKGROUND:

There is limited data suggesting that recovery from severe pulmonary infection with Coccidioides may be hastened by the addition of systemic corticosteroids.

METHODS:

We present a case report of 2 patients with persistent and progressive coccidioidomycosis who demonstrated a dramatic response to adjunctive corticosteroid therapy.

RESULTS:

Both patients had Coccidioides immitis cultured from respiratory samples. One was a 69-year-old man who had been treated with combination fluconazole and liposomal amphotericin for over 6 weeks, with persistent fever and pneumonia. The other was a 61-year-old man treated with fluconazole and then amphotericin for 3 weeks, with progression to acute respiratory distress syndrome and shock. Both received short courses of intravenous methylprednisolone and recovered to be discharged home.

CONCLUSIONS:

As opposed to associated hypersensitivity, corticosteroid treatment in these cases was directed at modulating the ongoing destructive effects of unchecked inflammation. Rapid improvement was noted in both cases and raises the possibility that the addition of systemic corticosteroids may hasten recovery in patients with severe coccidioidomycosis.

• Authors: Melisa R Chang, Neha Chopra, David Beenhouwer, Matthew B Goetz, Guy W Soo Hoo
• Journal: The American journal of medicine (Am J Med) Vol. 132 Issue 1 Pg. 110-113 (01 2019) ISSN: 1555-7162 [Electronic] United States
• PMID: 30290191 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright © 2019. Published by Elsevier Inc.

Chemical References

• Glucocorticoids
• Methylprednisolone

Topics

• Aged
• Coccidioidomycosis (drug therapy)
• Glucocorticoids (therapeutic use)
• Humans
• Male
• Methylprednisolone (therapeutic use)
• Middle Aged